In a qui tam action filed under the False Claims Act, the relator, Barbara Senters, appealed the district court’s dismissal of her fourth amended complaint (FAC), which alleged that Quest Diagnostics submitted false claims...more
8/19/2025
/ Amended Complaints ,
Appeals ,
Appellate Courts ,
Clinical Laboratory Testing ,
Dismissals ,
False Claims Act (FCA) ,
Federal Rules of Civil Procedure ,
Healthcare Fraud ,
Lack of Specificity ,
Pleading Standards ,
Pleadings ,
Qui Tam ,
Rule 9(b) ,
Whistleblowers
Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve allegations of violating the False Claims Act and Anti-Kickback Statute arising from purported...more
10/16/2024
/ Anti-Kickback Statute ,
Co-payments ,
Criminal Penalties ,
Deferred Prosecution Agreements ,
Enforcement Actions ,
False Claims Act (FCA) ,
Healthcare Fraud ,
Kickbacks ,
Medicare ,
Medicare Part B ,
Medicare Part D ,
Patient Assistance Programs ,
Pharmaceutical Industry ,
Prescription Drugs ,
Price-Fixing ,
Private Foundations ,
Teva Pharmaceuticals